Objective To provide an update on key safety metrics after transfusion of convalescent plasma
in hospitalized coronavirus 2019 (COVID-19) patients, having previously demonstrated …

BACKGROUND Convalescent plasma is the only antibody-based therapy currently available
for patients with coronavirus disease 2019 (COVID-19). It has robust historical precedence …

Background Polyclonal convalescent plasma may be obtained from donors who have
recovered from coronavirus disease 2019 (Covid-19). The efficacy of this plasma in preventing …

Management of coccidioidomycosis first involves recognizing that a coccidioidal infection
exists, defining the extent of infection, and identifying host factors that predispose to disease …

Background Convalescent plasma has been widely used to treat coronavirus disease 2019 (Covid-19)
under the presumption that such plasma contains potentially therapeutic …

It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …

Coccidioidomycosis is an endemic fungal infection of the southwestern United States.
Normally a self-limited infection in healthy hosts, coccidioidomycosis can become a serious …

The cephalosporins are a large group of related β-lactam antimicrobial agents. Favorable
attributes of the cephalosporins include low rates of toxicity, relatively broad spectrum of activity…

Background: In the United States, female physicians working in academic medical practices
are less likely to achieve the academic rank of associate professor or professor than are …

Serologic studies are an important diagnostic tool in the clinical evaluation and follow-up of
persons with coccidioidomycosis. Numerous types of serologic tests are available, including …